JINXIN FERT.GRP HD-00001
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. It offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF … Read more
JINXIN FERT.GRP HD-00001 (3NX) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, JINXIN FERT.GRP HD-00001 (3NX) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
JINXIN FERT.GRP HD-00001 - Net Assets Trend (None–None)
This chart illustrates how JINXIN FERT.GRP HD-00001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for JINXIN FERT.GRP HD-00001 (None–None)
The table below shows the annual net assets of JINXIN FERT.GRP HD-00001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to JINXIN FERT.GRP HD-00001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
JINXIN FERT.GRP HD-00001 Competitors by Market Cap
The table below lists competitors of JINXIN FERT.GRP HD-00001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Integra LifeSciences Holdings
NASDAQ:IART
|
$536.88 Million |
|
ADENTRA INC.
F:UQ0
|
$537.15 Million |
|
Care Property Invest NV
BR:CPINV
|
$537.19 Million |
|
Guangzhou Risong Intelligent Technology Holding Co Ltd
SHG:688090
|
$537.21 Million |
|
Fleury S.A.
SA:FLRY3
|
$536.55 Million |
|
Kuyas Yatirim AS
IS:KUYAS
|
$536.46 Million |
|
Tele Columbus AG
LSE:0R50
|
$536.46 Million |
|
Sdiptech AB
LSE:0AAV
|
$536.37 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in JINXIN FERT.GRP HD-00001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares JINXIN FERT.GRP HD-00001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently JINXIN FERT.GRP HD-00001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares JINXIN FERT.GRP HD-00001's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $1,542,527,848
- Average return on equity (ROE) among peers: 7.82%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| JINXIN FERT.GRP HD-00001 (3NX) | €- | N/A | N/A | $536.60 Million |
| Raffles Medical Group Ltd (02M1) | $1.04 Billion | 8.64% | 0.46x | $548.22 Million |
| China Resources Medical Holdings Company Limited (1PH) | $6.14 Billion | 6.37% | 0.28x | $264.86 Million |
| Apollo Medical Holdings Inc (3AM) | $510.64 Million | 13.50% | 0.70x | $820.67 Million |
| NUVERRA ENVIR SOL (3H5) | $548.43 Million | -8.67% | 2.25x | $95.85 Million |
| Wenzhou Kangning Hospital Co. Ltd (4WK) | $1.04 Billion | 6.61% | 0.54x | $9.60 Million |
| Medicover AB (5M0B) | $562.10 Million | 18.11% | 2.00x | $967.15 Million |
| Ambea AB (publ) (6MA) | $4.68 Billion | 7.82% | 2.82x | $937.47 Million |
| Eifelhöhen-Klinik AG (EIF) | $18.66 Million | 24.17% | 2.10x | $4.38 Million |
| Garofalo Health Care S.p.A (GHC) | $333.14 Million | 6.51% | 1.55x | $126.70 Million |
| GZ4 (GZ4) | $545.91 Million | -4.85% | 4.17x | $116.32 Million |